Pre-emption Limits Survive Congress, But Will Face Supreme Court
This article was originally published in The Tan Sheet
Executive Summary
The FDA reauthorization law signed by President Bush Sept. 27 includes provisions intended to sustain limits on federal pre-emption, but the concept is challenged in several ongoing cases that could reach the Supreme Court in coming sessions
You may also be interested in...
FDA’s Chief Scientist Has Full Plate To Concentrate On: Clinical Research
FDA Chief Scientist Frank Torti will be asked to concentrate on clinical research when he assumes the newly created position in May, the agency says
FDA’s Chief Scientist Has Full Plate To Concentrate On: Clinical Research
FDA Chief Scientist Frank Torti will be asked to concentrate on clinical research when he assumes the newly created position in May, the agency says
FDA Stymied By Reauthorization Terms That May Slow Ingredient Development
FDA is stumped on interpreting and enforcing a provision in the FDA Amendments Act of 2007 that could have a chilling effect on development of new functional food and dietary supplement ingredients, an FDA official and an industry leader say
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: